BIAFW
bioAffinity Technologies, Inc.
NasdaqCMUSDEQUITY
DELAYED
Last price
0.12
▲ 0.01 (11.70%)
MARKET · —
Price
Open
0.08
Prev close
0.10
Day high
0.12
Day low
0.08
Volume
4.05K
Market cap
—
P/E (TTM)
—
52W range
0.08 – 0.12
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)$5.90M
Gross profit$2.04M
EBITDA$-11.97M
Net income$-15.19M
EPS (TTM)—
Free cash flow$-6.91M
Total cash$2.43M
Total debt$1.44M
Book value / share$0.56
Shares outstanding—
Float7.98M
Short % of float—
Dividend yield—
Beta (5Y)-1.05
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.21
EV / revenue—
EV / EBITDA—
Gross margin34.61%
Operating margin-220.77%
Profit margin-257.33%
Return on equity-1860.15%
Return on assets-125.11%
Debt / equity38.08
Current ratio1.44
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2022 |
|---|---|---|
| Total revenue | $9.36M | $4.80K |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| R&D | — | — |
| SG&A | — | — |
| Operating income | — | — |
| Pre-tax income | — | — |
| Tax provision | $0 | $0 |
| Net income | -$9.04M | -$8.15M |
| EBIT | $0 | $0 |
| Line item | 2024 | 2022 |
|---|---|---|
| Cash & equivalents | — | — |
| Short-term investments | — | — |
| Net receivables | — | — |
| Inventory | — | — |
| Total current assets | — | — |
| Total assets | — | — |
| Total current liabilities | — | — |
| Long-term debt | — | — |
| Total liabilities | — | — |
| Retained earnings | — | — |
| Shareholder equity | — | — |
| Line item | 2024 | 2022 |
|---|---|---|
| Net income | -$9.04M | -$8.15M |
| Depreciation | — | — |
| Change in working capital | — | — |
| Operating cash flow | — | — |
| Capital expenditure | — | — |
| Investing cash flow | — | — |
| Dividends paid | — | — |
| Buybacks | — | — |
| Financing cash flow | — | — |
| Net change in cash | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
-1.05
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
Business Wire · 2d ago
bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung
InvestorsHub · 4d ago
BC-Most Active Stocks
Associated Press · 4d ago
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung
Business Wire · 4d ago
WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
PR Newswire · 8d ago
BioAffinity Technologies Closes $4 Million Private Placement
MT Newswires · 8d ago
bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
Business Wire · 8d ago
WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
PR Newswire · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.